Crossmark

Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease

Crossref DOI link: https://doi.org/10.1016/j.medcle.2024.01.018

Published Print: 2024-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cantarelli, Lorenzo

Gutiérrez Valencia, Marta

Leache Alegria, Leire

Sainz Fernandez, Luis Carlos

Erviti Lopez, Juan

Gutiérrez Nicolas, Fernando

Nazco Casariego, Gloria Julia
License Information

Text and Data Mining valid from 2024-07-01

Text and Data Mining valid from 2024-07-01

stm-asf valid from 2024-07-01

stm-asf valid from 2024-07-01

stm-asf valid from 2024-07-01

stm-asf valid from 2024-07-01

stm-asf valid from 2024-07-01
More Information

This article is maintained by: Elsevier

Article Title: Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2024.01.018

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.